NCT03402997View on ClinicalTrials.gov

Tissue Resistivity in Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

September 25, 2019

Study Completion Date

September 25, 2019

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Resistivity measurement

To measure and compare the tissue impedance values obtained by analysing ex vivo non-neoplastic (healthy and peritumoral) and neoplastic breast tissues

Trial Locations (1)

6850

Ospedale Regionale di Mendrisio, Mendrisio

All Listed Sponsors
collaborator

Politecnico di Milano

OTHER

collaborator

Clinical Trial Unit Ente Ospedaliero Cantonale

OTHER

lead

Ente Ospedaliero Cantonale, Bellinzona

OTHER

NCT03402997 - Tissue Resistivity in Breast Cancer Patients | Biotech Hunter | Biotech Hunter